ARRINGTON KENNETH L has a total of 13 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are NII FARMAKOL AKAD MED, INNOV17 LLC and FABRICA ESPANOLA DE PRODUCTOS QUIM Y FARMACEUTICOS S A FAES.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Arrington Kenneth L | 13 |
#2 | Fraley Mark E | 12 |
#3 | Hartman George D | 8 |
#4 | Huang Shaei Y | 3 |
#5 | Garbaccio Robert M | 3 |
#6 | Lindsley Craig W | 2 |
#7 | Kreatsoulas Constantine | 2 |
#8 | Hoffman William F | 2 |
#9 | Yang Feng | 2 |
#10 | Steen Justin T | 2 |
Publication | Filing date | Title |
---|---|---|
US2009233896A1 | Inhibitors of checkpoint kinases | |
WO03106417A1 | Mitotic kinesin inhibitors |